Alciparum in south-west Tanzania. Malar J 2007, six:2. Kamugisha E, Jing S, Minde M, Kataraihya J, Kongola G, Kironde F, Swedberg G: Efficacy of artemether-lumefantrine in treatment of malaria among under-fives and prevalence of drug resistance markers in Igombe-Mwanza, north-western Tanzania. Malar J 2012, 11:58. Minja DT, Schmiegelow C, Mmbando B, Bostrom S, Oesterholt M, Magistrado P, Pehrson C, John D, Salanti A, Luty AJ, Lemnge M, Theander T, Lusingu J, Alifrangis M: Plasmodium falciparum mutant haplotype infection22.23.24.25.26.27.28.29.30.31.32.33.34. 35.36.in the course of pregnancy related to decreased birthweight, Tanzania. Emerg Infect Dis 2013, 19: doi: 10.3201. Alifrangis M, Lusingu JP, Mmbando B, Dalgaard MB, Vestergaard LS, Ishengoma D, Khalil IF, Theander TG, Lemnge MM, Bygbjerg IC: Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation with the 581G mutation inside the P.Price of 1H-Pyrazole-3-carbaldehyde falciparum dihydropteroate synthase gene. Am J Trop Med Hyg 2009, 80:523?27. Malisa AL, Pearce RJ, Mutayoba BM, Abdullah S, Mshinda H, Kachur PS, Bloland P, Roper C: The evolution of pyrimethamine resistant dhfr in Plasmodium falciparum of south-eastern Tanzania: comparing choice below SP alone vs SP + artesunate mixture. Malar J 2011, ten:317. Pearce RJ, Ord R, Kaur H, Lupala C, Schellenberg J, Shirima K, Manzi F, Alonso P, Tanner M, Mshinda H, Roper C, Schellenberg D: A communityrandomized evaluation of the impact of intermittent preventive remedy in infants on antimalarial drug resistance in southern Tanzania. J Infect Dis 2013, 207:848?59. Iriemenam NC, Shah M, Gatei W, van Eijk AM, Ayisi J, Kariuki S, Vanden EJ, Owino SO, Lal AA, Omosun YO, Otieno K, Desai M, ter Kuile FO, Nahlen B, Moore J, Hamel MJ, Ouma P, Slutsker L, Shi YP: Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya. Malar J 2012, 11:134. Raman J, Small F, Roper C, Kleinschmidt I, Cassam Y, Maharaj R, Barnes KI: Five years of large-scale dhfr and dhps mutation surveillance following the phased implementation of artesunate plus sulfadoxine-pyrimethamine in Maputo Province, Southern Mozambique.SM-102 web Am J Trop Med Hyg 2010, 82:788?94.PMID:24257686 Doumbo S, Ongoiba OA, Doumtabe D, Dara A, Ouologuem TD, Kayentao K, Djimde A, Traore B, Doumbo OK: [Prevalence of Plasmodium falciparum, anemia and molecular markers of chloroquine and sulfadoxinepyrimethamine resistance in delivered women in Fana, Mali] (in French). Bull Soc Pathol Exot 2013, 106:188?92. Duah NO, Quashie NB, Abuaku BK, Sebeny PJ, Kronmann KC, Koram KA: Surveillance of molecular markers of Plasmodium falciparum resistance to sulphadoxine-pyrimethamine 5 years right after the transform of malaria remedy policy in Ghana. Am J Trop Med Hyg 2012, 87:996?003. Ndiaye M, Tine R, Faye B, Ndiaye JL, Diouf I, Lo AC, Sylla K, Dieng Y, Hallett R, Alifrangis M, Gaye O: Collection of antimalarial drug resistance following intermittent preventive remedy of infants and young children (IPTi/c) in Senegal. C R Biol 2013, 336:295?00. Allen EN, Small F, Camba T, Cassam Y, Raman J, Boulle A, Barnes KI: Efficacy of sulphadoxine-pyrimethamine with or without the need of artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in southern Mozambique: a randomized controlled trial. Malar J 2009, eight:141. Gutman J, Mwandama D, Wiegand RE, Ali D, Mathanga DP, Skarbinski J: Effectiveness of inter.